MDT

99.08

-0.7%↓

A

146.15

-0.93%↓

VEEV

242.59

+1.29%↑

HQY

97.21

-0.08%↓

PHR.US

16.97

-2.64%↓

MDT

99.08

-0.7%↓

A

146.15

-0.93%↓

VEEV

242.59

+1.29%↑

HQY

97.21

-0.08%↓

PHR.US

16.97

-2.64%↓

MDT

99.08

-0.7%↓

A

146.15

-0.93%↓

VEEV

242.59

+1.29%↑

HQY

97.21

-0.08%↓

PHR.US

16.97

-2.64%↓

MDT

99.08

-0.7%↓

A

146.15

-0.93%↓

VEEV

242.59

+1.29%↑

HQY

97.21

-0.08%↓

PHR.US

16.97

-2.64%↓

MDT

99.08

-0.7%↓

A

146.15

-0.93%↓

VEEV

242.59

+1.29%↑

HQY

97.21

-0.08%↓

PHR.US

16.97

-2.64%↓

Search

Nektar Therapeutics

Aperta

41.53 -4.07

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

41.25

Massimo

43.66

Metriche Chiave

By Trading Economics

Entrata

6.1M

-36M

Vendite

615K

12M

EPS

-1.87

Margine di Profitto

-301.289

Dipendenti

61

EBITDA

6.9M

-29M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+138.36% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-235M

905M

Apertura precedente

45.6

Chiusura precedente

41.53

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Nektar Therapeutics Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2026, 23:11 UTC

Utili

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 gen 2026, 22:55 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 gen 2026, 21:39 UTC

I principali Market Mover

Raytheon Down Following Trump Post Criticizing Company

7 gen 2026, 20:13 UTC

I principali Market Mover

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 gen 2026, 20:03 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 gen 2026, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 gen 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 gen 2026, 22:48 UTC

Discorsi di Mercato

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 gen 2026, 22:46 UTC

Utili

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 gen 2026, 22:45 UTC

Utili

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 gen 2026, 22:42 UTC

Utili

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 gen 2026, 22:40 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 gen 2026, 22:31 UTC

Discorsi di Mercato

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 gen 2026, 22:22 UTC

Discorsi di Mercato

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 gen 2026, 22:01 UTC

Discorsi di Mercato

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 gen 2026, 21:46 UTC

Discorsi di Mercato

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 gen 2026, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 gen 2026, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 gen 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 gen 2026, 20:29 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 gen 2026, 20:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 gen 2026, 19:58 UTC

Discorsi di Mercato

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 gen 2026, 19:48 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Confronto tra pari

Modifica del prezzo

Nektar Therapeutics Previsione

Obiettivo di Prezzo

By TipRanks

138.36% in crescita

Previsioni per 12 mesi

Media 103.71 USD  138.36%

Alto 135 USD

Basso 30 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Nektar Therapeutics - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

8 ratings

6

Acquista

1

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

0.5949 / 0.7406Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

help-icon Live chat